Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by 1hot-techwomanon Feb 09, 2022 12:10pm
103 Views
Post# 34412883

RE:RE:Market beat on WEED is good for entire sector !!!

RE:RE:Market beat on WEED is good for entire sector !!!
Lvlchange wrote: Link doesn't work


Works fine for me :) here ya go.....



Canopy Growth shares rally after revenue beats analyst target

0

 

 

Referenced Symbols

 

An earlier version of this report had a revenue number that does not compare with consensus. It has been corrected.

Canopy Growth Corp. CGC, +15.34% WEED, +15.66% said Wednesday its third-quarter net loss narrowed to C$108.93 million ($85.8 million), or 28 cents a share, from C$904.38 million, or C$2.43 a share, in the year-ago period. Revenue at the cannabis company fell to C$140.9 million from C$152.5 million a year ago. Analysts expected Canopy Growth to lose 28 cents a share on revenue of C$135.9 million, according to a FactSet survey. Growth in consumer products such as BioSteel drinks and Storz & Bickel vapes was offset by a decline in Canadian cannabis sales. The company said it maintained its No. 1 position in the premium flower market in Canada. Shares of Canopy Growth shares jumped 7.8% in premarket trades.


<< Previous
Bullboard Posts
Next >>